Compare BDTX & SPEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BDTX | SPEG |
|---|---|---|
| Founded | 2014 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.1M | 154.3M |
| IPO Year | 2020 | 2025 |
| Metric | BDTX | SPEG |
|---|---|---|
| Price | $2.60 | $10.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $10.40 | N/A |
| AVG Volume (30 Days) | ★ 974.8K | 44.0K |
| Earning Date | 03-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | ★ $70,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.01 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.20 | $9.95 |
| 52 Week High | $4.94 | $11.03 |
| Indicator | BDTX | SPEG |
|---|---|---|
| Relative Strength Index (RSI) | 45.19 | N/A |
| Support Level | $2.36 | N/A |
| Resistance Level | $2.70 | N/A |
| Average True Range (ATR) | 0.15 | 0.00 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 48.08 | 0.00 |
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Silver Pegasus Acquisition Corp is a blank check company.